Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Proteoglycans01:05

Proteoglycans

4.5K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.5K
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

3.4K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
3.4K
Protein Glycosylation01:25

Protein Glycosylation

9.0K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
9.0K
Glycocalyx and its Functions01:14

Glycocalyx and its Functions

7.4K
The glycocalyx is a carbohydrate-rich, fuzzy-appearing layer on the outer surface of the cell membrane. It is highly hydrophilic, because of this it attracts large amounts of water to the cell's surface. This aids the cell's interaction with the watery environment and also helps it to obtain substances dissolved in the water. It is also important for cell identification, self/non-self determination, and embryonic development and is used in cell-to-cell attachments to form tissues.
7.4K
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

4.0K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Point-of-care GlycoStrips detect serum and salivary antibodies to blood group antigens and pathogens.

Trends in biotechnology·2026
Same author

Introduction to a Special Issue of Glycobiology-Glycobiology Reviews Cancer.

Glycobiology·2026
Same author

The Practices of Pancreatic Neck Margin Testing and Their Outcomes after Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.

Annals of surgical oncology·2026
Same author

N-glycopedia: libraries for native N-glycan structural analysis.

Nature communications·2026
Same author

Disrupted O-GalNAc glycosylation as a mechanism and biomarker of <i>SLC35A2</i>-associated epilepsy.

bioRxiv : the preprint server for biology·2026
Same author

Deletion of Core 1 β3GalT-specific molecular chaperone (Cosmc) in murine intestinal epithelia leads to major alterations in glycocalyx and tumorigenesis.

The Journal of biological chemistry·2026

Related Experiment Video

Updated: Dec 23, 2025

Glycan Node Analysis: A Bottom-up Approach to Glycomics
11:36

Glycan Node Analysis: A Bottom-up Approach to Glycomics

Published on: May 22, 2016

11.1K

O-glycan recognition and function in mice and human cancers.

Gabrielle E Cervoni1, Jane J Cheng1, Kathryn A Stackhouse1

  • 1Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, CLS 11087, 3 Blackfan Circle, Boston, MA 02115, U.S.A.

The Biochemical Journal
|April 30, 2020
PubMed
Summary

Altered O-glycosylation in tumor cells, involving specific oligosaccharides, impacts cancer development and serves as biomarkers. Understanding these changes offers new avenues for cancer diagnostics and therapeutics.

Keywords:
O-glycansglycan functionglycan recognitionhuman cancershuman glycansmouse glycans

More Related Videos

Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay
09:13

Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay

Published on: July 13, 2017

9.8K
Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
13:36

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Published on: October 20, 2023

4.0K

Related Experiment Videos

Last Updated: Dec 23, 2025

Glycan Node Analysis: A Bottom-up Approach to Glycomics
11:36

Glycan Node Analysis: A Bottom-up Approach to Glycomics

Published on: May 22, 2016

11.1K
Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay
09:13

Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay

Published on: July 13, 2017

9.8K
Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
13:36

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Published on: October 20, 2023

4.0K

Area of Science:

  • Biochemistry
  • Glycobiology
  • Oncology

Background:

  • Protein glycosylation, a common post-translational modification, has significant pathological consequences when altered.
  • O-glycosylation, the attachment of N-acetylgalactosamine (GalNAc) to serine/threonine residues, produces diverse oligosaccharides crucial for cell function.
  • Tumor cells exhibit distinct O-glycan profiles compared to normal cells, making them key areas of research.

Purpose of the Study:

  • To explore O-glycosylation in murine and human tumor cells, focusing on colorectal, breast, and pancreatic cancers.
  • To detail the structure, function, and recognition of O-glycans in the context of cancer.
  • To highlight the potential of O-glycosylation knowledge for developing novel cancer diagnostics and therapeutics.

Main Methods:

  • Review of existing literature on O-glycosylation in cancer.
  • Analysis of O-glycan structures and their expression patterns in various tumor types.
  • Examination of the role of O-glycans as tumor-associated carbohydrate antigens (TACAs).

Main Results:

  • Tumor cells characteristically display altered O-glycan structures, both quantitatively and qualitatively.
  • Specific O-glycans, such as Tn antigen and sialyl-Tn antigen (STn), are prevalent in carcinomas and contribute to tumor progression.
  • Altered O-glycans function as valuable circulating tumor biomarkers (e.g., CA19-9, CA-125) and immunohistochemical markers.

Conclusions:

  • O-glycosylation patterns are significantly dysregulated in cancer cells.
  • Tumor-associated O-glycans offer promising targets for cancer diagnosis and staging.
  • Exploiting the understanding of tumor O-glycosylation presents substantial opportunities for advancing cancer treatment strategies.